This is a secondary study on top of the continued open access. More a long term effects study..
Considering their have been at least 3 occasions since this study was launched in November 2020, that ACADIA have done Press Conf/Presentations and have been, I believe, fairly positive on Trof (the snippets etc have been recorded in previous posts), I am pretty up beat on them launching this study. It will even be more money they are willing to lock up in Trof's development.
Do your Own Research. This is my opinion only!
new trial Trofinetide, page-7
-
- There are more pages in this discussion • 43 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$20.17 |
Change
0.070(0.35%) |
Mkt cap ! $2.578B | |||
| Open | High | Low | Value | Volume |
| $20.39 | $20.53 | $20.14 | $4.102M | 202.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 249 | $20.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $20.31 | 790 | 1 |
View Market Depth
| Last trade - 16.10pm 26/07/2024 (20 minute delay) ? |
| NEU (ASX) Chart |